A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs TRC 101 (Primary)
  • Indications Acidosis; Kidney disorders; Renal failure
  • Focus Adverse reactions; First in man
  • Sponsors Tricida
  • Most Recent Events

    • 08 Nov 2017 According to a Tricida media release, the results of this trial have been published in the Clinical Journal of the American Society of Nephrology (CJASN).
    • 01 Nov 2017 According to Tricida media release, data from this trial will be presented at ASN Kidney Week 2017 .
    • 09 Jan 2017 Topline results published in a Tricida media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top